Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

Contributed by: PR Newswire

Tags

Sobi-Innate-Partners

More Like This

Sobi share new clinical data across multiple hematologic diseases at EHA 2025

Sobi showcases new data across rare inflammatory conditions at ACR 2025

BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®

Business Wire logo

Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors

Kyowa Kirin Announces Positive Interim Real-world Data for Mogamulizumab (Poteligeo®) in Cutaneous T-cell Lymphoma at EORTC-CLTG 2024

Sobi to share new clinical data and research at EULAR 2025

Sobi to present new data at ASH 2023 Annual Meeting

Business Wire logo

Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi®)